IPO Boutique

Kythera Biopharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Kythera Biopharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Kythera Biopharmaceuticals, Inc.KYTH -
NASDAQ
$14.00-$16.00 $16.00 $18.495.1 million10/11/2012
J.P. Morgan, Goldman Sachs & Co.
Co-Manager(s):
Leerink Swann, Lazard Capital Markets
Health Care
Filing(s):

Filed 2012-05-17



Kythera Biopharmaceuticals, Inc. Quote & Chart - Click for current quote - KYTH

About Kythera Biopharmaceuticals, Inc. (adapted from Kythera Biopharmaceuticals, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market.

This description is adapted from KYTHERA, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as KYTHERA, Inc. "KYTH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved